Low‐Load Quadriceps Strengthening With Blood Flow Restriction in Adults With Haemophilic Knee Arthropathy: A Randomised Controlled Trial
Haemophilia · 2025
DOI: 10.1111/hae.70197 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Haemophilia, 2025. Verfasst von Mar Villalón-González und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiotherapy, University of Murcia, Murcia, Spain. Hauptthemen laut MEDLINE: Quadriceps Muscle, Hemophilia A, Knee Joint, Blood Flow Restriction Therapy. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Swedish Orphan Biovitrum S.L..
Abstract (Originalsprache)
Introduction
Haemophilic knee arthropathy leads to a reduction in muscle mass and strength. Blood flow restriction (BFR) involves the application of a compressive cuff that enables strength training with reduced loads.
Objective
To evaluate safety as the primary outcome and the efficacy (muscle strength and activation, functional capacity and quality of life) as secondary outcomes of a quadriceps strengthening programme using BFR in patients with haemophilia.
Methods
A randomised clinical trial was conducted with 33 participants assigned to either an experimental group (strength training with BFR) or a control group. The 4‐week intervention included three weekly sessions and two strength exercises (leg extension and squat). Outcomes assessed were safety (clinical hemarthrosis), strength (dynamometry), muscle activation (surface electromyography), pain threshold (pressure algometry), range of motion (goniometry), functional capacity (Timed Up and Go) and quality of life (36‐Item Short Form Survey). Follow‐up assessments were performed 4 weeks post‐intervention to evaluate effect persistence.
Results
Thirty participants completed the study. No participants experienced clinical hemarthrosis or hematomas during the intervention, confirming safety as the primary outcome. Additionally, BFR training produced significant gains in quadriceps strength ( p < 0.001; η 2 p = 0.19) and activation ( p < 0.001; η 2 p = 0.28). Further improvements ( p < 0.05) were observed in pain threshold, knee range of motion and the physical component of quality of life.
Conclusion
BFR strength training is safe for patients with haemophilia. It may enhance quadriceps strength and activation, raise pain thresholds and improve knee mobility. Patients show better physical functioning, less bodily pain and improved physical quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiotherapy, University of Murcia, Murcia, Spain.
- InHeFis Research Group, Instituto Asturiano de Investigación Sanitaria (ISPA), Oviedo, Spain.
- Department of Basic Phycology and Methodology, University of Murcia., Murcia, Spain.
- Department of Surgery and Medical-Surgical Specialties, University of Oviedo, Oviedo, Spain.
- Department of Physiotherapy, Catholic University San Antonio-UCAM, Murcia, Spain.
ORCID-Profile: Raúl Pérez-Llanes, José Antonio López-Pina, Rubén Cuesta-Barriuso, Elena Donoso-Úbeda
Förderung
- Swedish Orphan Biovitrum S.L.
Zitieren
APA
Villalón-González, M., Pérez-Llanes, R., López-Pina, J. A., Cuesta-Barriuso, R., & Donoso-Úbeda, E. (2025). Low‐Load Quadriceps Strengthening With Blood Flow Restriction in Adults With Haemophilic Knee Arthropathy: A Randomised Controlled Trial. Haemophilia. https://doi.org/10.1111/hae.70197
Vancouver
Villalón-González M, Pérez-Llanes R, López-Pina JA, Cuesta-Barriuso R, Donoso-Úbeda E. Low‐Load Quadriceps Strengthening With Blood Flow Restriction in Adults With Haemophilic Knee Arthropathy: A Randomised Controlled Trial. Haemophilia. 2025. doi:10.1111/hae.70197
BibTeX
@article{VillalnGonzlez2025,
author = {Villalón-González, Mar and Pérez-Llanes, Raúl and López-Pina, José Antonio and Cuesta-Barriuso, Rubén and Donoso-Úbeda, Elena},
title = {Low‐Load Quadriceps Strengthening With Blood Flow Restriction in Adults With Haemophilic Knee Arthropathy: A Randomised Controlled Trial},
journal = {Haemophilia},
year = {2025},
doi = {10.1111/hae.70197}
}
EUVIMED